Visser J W, de Vries P, Hogeweg-Platenburg M G, Bayer J, Schoeters G, van den Heuvel R, Mulder D H
Institute of Applied Radiobiology and Immunology TNO, Department of Cell Biology, Rijswijk, The Netherlands.
Semin Hematol. 1991 Apr;28(2):117-25.
The results of the Y-chromosome in situ hybridization experiments, the MRA assessment, and the long-term production of CFU-GM in vitro indicate that our protocol to sort low density WGA+, 15/1.1-, Rh123 dull cells enriches about 200-fold for PHSC. Assays for spleen colony formation (CFU-S) and radioprotection (30-day survival) were shown to be unspecific for PHSC, and, therefore, we lack a quantitative PHSC assay. The absolute number of PHSC in the bone marrow is not known any more, the purity of our sorted population likewise is unknown. Long-term repopulating cells (PHSC) could be separated from short-term repopulating ones by using Rh123 staining. The short-term repopulating cells (Rh123 bright) provided sufficient offspring to protect lethally irradiated mice until endogenous PHSC could reconstitute hematopoiesis. These cells are therefore of interest for bone marrow transplantation, because they provide radioprotection without long-term repopulation and graft-versus-host disease. For gene therapy these cells are of limited use, and PHSC with extensive replication are needed. The PHSC were not cultured successfully. Less than 15% of the sorted Rh123 dull cells responded in semisolid or liquid cultures in the presence of growth factors. Proliferation without differentiation was not observed. This may indicate that the right growth factor has not been found yet. On the other hand, about 30% of the cells responded in stromal layers of long-term bone marrow cultures and prolonged CFU-GM production and cobblestone area formation were observed there, suggesting that cell-cell contact and adherence molecules play a regulatory role in PHSC replication.(ABSTRACT TRUNCATED AT 250 WORDS)
Y染色体原位杂交实验、MRA评估以及体外长期CFU-GM生成的结果表明,我们分选低密度WGA+、15/1.1-、Rh123暗淡细胞的方案使原始造血干细胞(PHSC)富集了约200倍。脾集落形成(CFU-S)和辐射防护(30天存活)检测对PHSC不具有特异性,因此,我们缺乏一种定量PHSC的检测方法。骨髓中PHSC的绝对数量已不再清楚,我们分选群体的纯度同样未知。通过使用Rh123染色,可将长期重建造血的细胞(PHSC)与短期重建造血的细胞分离。短期重建造血的细胞(Rh123明亮)可提供足够的子代,以保护受致死性照射的小鼠,直至内源性PHSC能够重建造血功能。因此,这些细胞对于骨髓移植具有重要意义,因为它们可提供辐射防护,而不会导致长期重建造血和移植物抗宿主病。对于基因治疗而言,这些细胞的用途有限,需要具有广泛增殖能力的PHSC。PHSC未能成功培养。在生长因子存在的情况下,分选得到的Rh123暗淡细胞中,不到15%在半固体或液体培养中出现反应。未观察到无分化的增殖现象。这可能表明尚未找到合适的生长因子。另一方面,约30%的细胞在长期骨髓培养的基质层中出现反应,并观察到CFU-GM生成延长和鹅卵石区形成,这表明细胞间接触和黏附分子在PHSC复制中起调节作用。(摘要截短于250字)